Concepedia

Sarah M. Schweitzer

SM

3

Publications

90

Citations

3

H-Index

2002

Active since

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Sarah M. Schweitzer is an author at Abbott Fund specializing in pharmacotherapy, pharmacokinetics, and medicine.

Top concepts

MedicinePharmacologyPharmacotherapyPharmacokineticsDrug SafetyDrug MonitoringPharmacodynamicsClinical ChemistryClinical PharmacologyMolecular Pharmacology

Publications per year

2002–2006

3

Publications

3

Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation

Allan M. Roza, Stephen J. Tomlanovich, Robert M. Merion et al. · Transplantation · 2002 · 40 citations

The Effects of Multiple Doses of Fenofibrate on the Pharmacokinetics of Pravastatin and Its 3α‐Hydroxy Isomeric Metabolite

Linda E. Gustavson, Sarah M. Schweitzer, Stephan Koehne‐Voss et al. · The Journal of Clinical Pharmacology · 2005 · 27 citations

Healthy Subjects, Pharmacotherapy, Experimental Pharmacology +17

Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects

Linda E. Gustavson, Sarah M. Schweitzer, David Burt et al. · Clinical Therapeutics · 2006 · 23 citations

Three-period Crossover Study, Healthy Subjects, Pharmacodynamics +6

Rows per page

1–3 of 3